Ables Iannone Moore & Associates’s Labcorp LH Stock Holding History

Ables Iannone Moore & Associates’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$300K	Hold	975	–	–	0.16%	52
2026 Q2	$273K	Hold	975	–	–	0.15%	56
2026 Q1	$260K	Sell	975 -240	-20%	-$65K	0.15%	55
2025 Q4	$305K	Sell	1,215 -10	-0.8%	-$2.66K	0.17%	54
2025 Q3	$352K	Sell	1,225 -250	-17%	-$67K	0.2%	51
2025 Q2	$387K	Sell	1,475 -75	-5%	-$18.3K	0.24%	49
2025 Q1	$361K	Hold	1,550	–	–	0.25%	46
2024 Q4	$356K	Sell	1,550 -75	-5%	-$17.2K	0.22%	47
2024 Q3	$364K	Hold	1,625	–	–	0.23%	47
2024 Q2	$331K	Hold	1,625	–	–	0.22%	47
2024 Q1	$355K	Hold	1,625	–	–	0.25%	46
2023 Q4	$369K	Buy	+1,625	New	+$341K	0.28%	46

Other funds holding LH

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $6.36B AUM 0.55% 1-Year Est. Return

Ables Iannone Moore & Associates's LH Position: Q3 2026 in Review

Ables Iannone Moore & Associates held its Labcorp (LH) position steady in Q3 2026 at 975 shares worth $300K. The position accounts for 0.16% of the portfolio, ranked #52.

Ables Iannone Moore & Associates first reported a position in LH in Q4 2023 and has held it in 12 quarters since. The position peaked at $387K in Q2 2025. 647 funds tracked by Wall St. Rank hold LH as of Q3 2026.

Ables Iannone Moore & Associates held 975 shares of Labcorp worth $300K as of Q3 2026.
Ables Iannone Moore & Associates left its Labcorp share count unchanged in Q3 2026.
Labcorp made up 0.16% of Ables Iannone Moore & Associates's portfolio in Q3 2026, its #52 holding.
Ables Iannone Moore & Associates first reported a position in Labcorp in Q4 2023 and has held it in 12 quarters since.
Ables Iannone Moore & Associates's Labcorp position peaked at $387K in Q2 2025.
647 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on Ables Iannone Moore & Associates's 13F filing for Q3 2026, filed 6 Oct 2026.